159 related articles for article (PubMed ID: 30658386)
1. Increased Mortality in
Rijken JA; van Hulsteijn LT; Dekkers OM; Niemeijer ND; Leemans CR; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Dreijerink KMA; van Dooren MF; Hes FJ; Jansen JC; Corssmit EPM; Hensen EF
Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30658386
[TBL] [Abstract][Full Text] [Related]
2. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
3. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
4. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
[TBL] [Abstract][Full Text] [Related]
5. Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients.
Huang Y; Wang LA; Xie Q; Pang J; Wang L; Yi Y; Zhang J; Zhang Y; Chen R; Lan W; Zhang D; Jiang J
Endocr Connect; 2018 Dec; 7(12):1217-1225. PubMed ID: 30352407
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
Benn DE; Gimenez-Roqueplo AP; Reilly JR; Bertherat J; Burgess J; Byth K; Croxson M; Dahia PL; Elston M; Gimm O; Henley D; Herman P; Murday V; Niccoli-Sire P; Pasieka JL; Rohmer V; Tucker K; Jeunemaitre X; Marsh DJ; Plouin PF; Robinson BG
J Clin Endocrinol Metab; 2006 Mar; 91(3):827-36. PubMed ID: 16317055
[TBL] [Abstract][Full Text] [Related]
7. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of chromogranin A in SDHx-related paragangliomas.
Zuber S; Wesley R; Prodanov T; Eisenhofer G; Pacak K; Kantorovich V
Eur J Clin Invest; 2014 Apr; 44(4):365-71. PubMed ID: 24467715
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
[TBL] [Abstract][Full Text] [Related]
11. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and genetic testing outcomes of patients with clinically suspected paraganglioma/pheochromocytoma (PGL/PCC) syndrome in Singapore.
Ting KR; Ong PY; Wei SOG; Parameswaran R; Khoo CM; Deepak DS; Lee SC
Hered Cancer Clin Pract; 2020 Dec; 18(1):24. PubMed ID: 33308260
[TBL] [Abstract][Full Text] [Related]
13. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma.
McWhinney SR; Pilarski RT; Forrester SR; Schneider MC; Sarquis MM; Dias EP; Eng C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5694-9. PubMed ID: 15531530
[TBL] [Abstract][Full Text] [Related]
14. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis.
van Hulsteijn LT; Dekkers OM; Hes FJ; Smit JW; Corssmit EP
J Med Genet; 2012 Dec; 49(12):768-76. PubMed ID: 23099648
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of paraganglioma syndromes.
Boedeker CC; Neumann HP; Offergeld C; Maier W; Falcioni M; Berlis A; Schipper J
Skull Base; 2009 Jan; 19(1):17-25. PubMed ID: 19568339
[TBL] [Abstract][Full Text] [Related]
17. No evidence for increased mortality in SDHD variant carriers compared with the general population.
van Hulsteijn LT; Heesterman B; Jansen JC; Bayley JP; Hes FJ; Corssmit EP; Dekkers OM
Eur J Hum Genet; 2015 Dec; 23(12):1713-6. PubMed ID: 25758995
[TBL] [Abstract][Full Text] [Related]
18. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
19. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
[TBL] [Abstract][Full Text] [Related]
20. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]